Myocardial Infarction Clinical Trial
Official title:
Intracoronary Scaffold Assessment a Randomised Evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI) A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction
The aim of the current study is to test the clinical performance of the everolimus-eluting BVS compared with that of the durable polymer everolimus-eluting stent (EES) in patients undergoing PCI in the setting of acute MI.
Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation currently
represents the dominant treatment strategy in patients undergoing catheter intervention.
However effective neointimal suppression occurs at the cost of a systematic delay in arterial
healing in comparison with after bare metal stenting. This underlies a small but significant
increased risk of stent thrombosis after DES implantation in comparison with bare metal stent
implantation as well as a possible excess of in-stent neoatheroma formation.
Bioresorbable vascular scaffolds (BVS) represent an innovative technology providing
short-term vessel scaffolding and drug delivery without the long-term limitations of metallic
DES and durable polymer coatings. Potential benefits include restoration of normal vasomotor
reactivity, facilitation of positive vessel wall remodelling and facilitation of subsequent
bypass grafting of the stented arterial segment. In addition preliminary reports suggest that
the process of scaffold biodegradation may promote formation of a cohesive tissue layer
covering and stabilizing the underlying atherosclerotic plaque - a so-called plaque-sealing
effect. Although initial results with BVS are encouraging, there is a lack of randomized
clinical trial data and no data exists for outcomes after BVS implantation in patients
undergoing coronary stenting in the setting of acute myocardial infarction (MI).
The aim of the current study is to test the clinical performance of the everolimus-eluting
BVS compared with that of the durable polymer everolimus-eluting stent (EES) in patients
undergoing PCI in the setting of acute MI. The primary endpoint will be percentage diameter
stenosis at protocol-mandated 6-8 month angiographic follow-up. Sample size calculation is
based on a non-inferiority assumption in relation to the BVS versus EES. It is planned to
enrol a total of 260 patients. Subsequent clinical follow-up will be undertaken out to 2
years.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06013813 -
Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI
|
N/A | |
Completed |
NCT04507529 -
Peer-mentor Support for Older Vulnerable Myocardial Infarction Patients
|
N/A | |
Recruiting |
NCT06066970 -
Cardiac Biomarkers for the Quantification of Myocardial Damage After Cardiac Surgery
|
||
Recruiting |
NCT03620266 -
Effects of Bilberry and Oat Intake After Type 2 Diabetes and/or MI
|
N/A | |
Completed |
NCT04097912 -
Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
|
||
Completed |
NCT04153006 -
Comparison of Fingerstick Versus Venous Sample for Troponin I.
|
||
Completed |
NCT03668587 -
Feasibility and Security of a Rapid Rule-out and rule-in Troponin Protocol in the Management of NSTEMI in an Emergency Departement
|
||
Recruiting |
NCT01218776 -
International Survey of Acute Coronary Syndromes in Transitional Countries
|
||
Completed |
NCT03076801 -
Does Choral Singing Help imprOve Stress in Patients With Ischemic HeaRt Disease?
|
N/A | |
Recruiting |
NCT05371470 -
Voice Analysis Technology to Detect and Manage Depression and Anxiety in Cardiac Rehabilitation
|
N/A | |
Recruiting |
NCT04562272 -
Attenuation of Post-infarct LV Remodeling by Mechanical Unloading Using Impella-CP
|
N/A | |
Completed |
NCT04584645 -
A Digital Flu Intervention for People With Cardiovascular Conditions
|
N/A | |
Active, not recruiting |
NCT04475380 -
Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
|
||
Not yet recruiting |
NCT06007950 -
Time-restricted Eating Study (TRES): Impacts on Anthropometric, Cardiometabolic and Cardiovascular Health
|
N/A | |
Withdrawn |
NCT05327855 -
Efficacy and Safety of OPL-0301 Compared to Placebo in Adults With Post-Myocardial Infarction (MI)
|
Phase 2 | |
Recruiting |
NCT02876952 -
High Intensity Aerobic Interval Training With Mediterranean Diet Recommendations in Post-Myocardial Infarct Patients
|
N/A | |
Completed |
NCT02917213 -
Imaging Silent Brain Infarct And Thrombosis in Acute Myocardial Infarction
|
||
Completed |
NCT02711631 -
Feasibility and Effectiveness of Remote Virtual Reality-Based Cardiac Rehabilitation
|
N/A | |
Completed |
NCT02382731 -
Interventions to Support Long-Term Adherence aNd Decrease Cardiovascular Events Post-Myocardial Infarction
|
N/A | |
Completed |
NCT02305602 -
A Study of VentriGel in Post-MI Patients
|
Phase 1 |